Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Conner Hazelrigg’s Sunshine Box lights up the dark in Haiti
Conner Hazelrigg, 23, never considered herself an entrepreneur. A few years ago, she was a student at William Jewell College, keeping herself busy playing tennis and basketball, and working towards a double major in physics and math. “I always wanted to do something with engineering and architecture — I loved science,” Hazelrigg said. “But I…
KC Crew Riverfront project casts Millenial net with sand volleyball, kickball
A new recreation sports complex is part of a series of developments along Berkley Riverfront Park that hope to attract more Millennials to downtown Kansas City. Kansas City-based rec sports league KC Crew has partnered with Port KC to open six sand volleyball courts and two kickball fields toward the east end of the park,…
What the Flokk? Startup to connect residents with area events
For Trey Rhedrick, the alarm sounds at 5 a.m. He rises before the sun to work at Black & Veatch as a chemical engineer project manager. When finished at 5 p.m., Rhedrick conducts a couple meetings for his other gig before heading home to snarf down dinner. For the next six to eight hours —…
Sprint Accelerator graduate acquired by medical giant
A large California-based health care provider recently announced that it acquired Medicast, a graduate of the Kansas City-based Sprint Mobile Health Accelerator program. Providence St. Joseph Health purchased the firm for an undisclosed amount for its logistics and management platform that automates remote care delivery. In 2014, Medicast participated in the inaugural, three-month program at…